1040314-69-9 Usage
Uses
Used in Organic Synthesis:
3-Amino-4-benzyloxypyridine is utilized as a key intermediate in organic synthesis for the preparation of various complex organic molecules. Its unique structure allows for versatile chemical reactions, facilitating the synthesis of a wide range of compounds.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, 3-Amino-4-benzyloxypyridine is employed as a building block for the development of pharmaceutical compounds. Its presence in the molecular structure can contribute to the desired biological activity and pharmacological properties of the final drug molecules.
Used in Pharmaceutical Industry:
3-Amino-4-benzyloxypyridine is used as a precursor in the synthesis of pharmaceutical compounds for various therapeutic applications. Its incorporation into drug molecules can enhance their efficacy, selectivity, and safety profiles, making it an essential component in the development of novel medications.
Used in Drug Design and Development:
3-Amino-4-benzyloxypyridine is utilized in drug design and development as a structural element that can be modified to optimize the pharmacokinetic and pharmacodynamic properties of drug candidates. Its presence in a molecule can influence factors such as solubility, stability, and bioavailability, which are critical for the success of a drug in clinical trials and eventual market approval.
Check Digit Verification of cas no
The CAS Registry Mumber 1040314-69-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,4,0,3,1 and 4 respectively; the second part has 2 digits, 6 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1040314-69:
(9*1)+(8*0)+(7*4)+(6*0)+(5*3)+(4*1)+(3*4)+(2*6)+(1*9)=89
89 % 10 = 9
So 1040314-69-9 is a valid CAS Registry Number.
1040314-69-9Relevant academic research and scientific papers
TETRACYCLIC HETEROCYCLE COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF HEPATITIS C
-
, (2014/08/20)
The present invention relates to compounds of formula (I) that are useful as hepatitis C virus (HCV) NS5B polymerase inhibitors, the synthesis of such compounds, and the use of such compounds for inhibiting HCV NS5B polymerase activity, for treating or preventing HCV infections and for inhibiting HCV viral replication and/or viral production in a cell-based system.
TETRACYCLIC HETEROCYCLE COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF HEPATITIS C
-
, (2014/08/20)
The present invention relates to compounds of formula I that are useful as hepatitis C virus (HCV) NS5B polymerase inhibitors, the synthesis of such compounds, and the use of such compounds for inhibiting HCV NS5B polymerase activity, for treating or preventing HCV infections and for inhibiting HCV viral replication and/or viral production in a cell-based system.
COMPOUNDS FOR THE TREATMENT OF HEPATITIS C
-
Page/Page column 82-83, (2011/10/05)
The disclosure provides ten specific compounds with a basic structure of pyrazolo [1, 5-a] pyridine, including their salts, as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and may be useful in treating those infected with HCV.
COMPOUNDS FOR THE TREATMENT OF HEPATITIS C
-
Page/Page column 84, (2010/04/06)
The disclosure provides compounds of formula I, II, III, IV, and V, including their salts, as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and may be useful in treating those infected with HCV.
